DK0652903T3 - Nyt humant rekombinant gammainterferon - Google Patents

Nyt humant rekombinant gammainterferon

Info

Publication number
DK0652903T3
DK0652903T3 DK92900077.6T DK92900077T DK0652903T3 DK 0652903 T3 DK0652903 T3 DK 0652903T3 DK 92900077 T DK92900077 T DK 92900077T DK 0652903 T3 DK0652903 T3 DK 0652903T3
Authority
DK
Denmark
Prior art keywords
human recombinant
gamma interferon
concerns
new human
new
Prior art date
Application number
DK92900077.6T
Other languages
English (en)
Inventor
Otto Slodowski
Joachim Boehm
Bernd Otto
Original Assignee
Fraunhofer Ges Forschung
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Forschung filed Critical Fraunhofer Ges Forschung
Application granted granted Critical
Publication of DK0652903T3 publication Critical patent/DK0652903T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK92900077.6T 1990-11-19 1991-11-14 Nyt humant rekombinant gammainterferon DK0652903T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4036856A DE4036856C1 (da) 1990-11-19 1990-11-19

Publications (1)

Publication Number Publication Date
DK0652903T3 true DK0652903T3 (da) 1998-03-30

Family

ID=6418557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92900077.6T DK0652903T3 (da) 1990-11-19 1991-11-14 Nyt humant rekombinant gammainterferon

Country Status (9)

Country Link
EP (1) EP0652903B1 (da)
JP (1) JP3219274B2 (da)
AT (1) ATE163651T1 (da)
AU (1) AU9026691A (da)
CA (1) CA2096532C (da)
DE (2) DE4036856C1 (da)
DK (1) DK0652903T3 (da)
ES (1) ES2114555T3 (da)
WO (1) WO1992008737A1 (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19535853C2 (de) * 1995-09-18 1999-04-01 Fraunhofer Ges Forschung Varianten des rekombinanten humanen Interferon-gamma, Verfahren zu ihrer Herstellung und ihre Verwendung
DE19604583C2 (de) * 1996-02-08 1999-11-18 Fraunhofer Ges Forschung Verfahren zur Synthese von löslichen, rekombinanten Proteinen aus Bakterienzellen
SK8292002A3 (en) 1999-11-12 2002-12-03 Maxygen Holdings Ltd A conjugate exhibiting interferon gamma activity, nucleotide sequence encoding for a polypeptide fraction of conjugate, an expression vector and a host cell containing nucleotide sequence, pharmaceutical composition comprising the same and use thereof
US7230081B1 (en) 1999-11-12 2007-06-12 Maxygen Holdings, Ltd. Interferon gamma conjugates
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
KR20030094336A (ko) * 2001-04-06 2003-12-11 맥시겐 홀딩스 엘티디 인터페론 감마 폴리펩티드 변이체
US7038015B2 (en) 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
WO2004005341A2 (en) 2002-07-03 2004-01-15 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
WO2020077257A1 (en) 2018-10-11 2020-04-16 Inhibrx, Inc. Pd-1 single domain antibodies and therapeutic compositions thereof
CA3115082A1 (en) 2018-10-11 2020-04-16 Inhibrx, Inc. B7h3 single domain antibodies and therapeutic compositions thereof
CN113518647A (zh) 2018-10-11 2021-10-19 印希比股份有限公司 5t4单域抗体及其治疗性组合物
EP3864045A2 (en) 2018-10-11 2021-08-18 Inhibrx, Inc. Dll3 single domain antibodies and therapeutic compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
IL75302A0 (en) * 1984-06-06 1985-09-29 Takeda Chemical Industries Ltd Novel polypeptide and production thereof
JPS6124599A (ja) * 1984-07-11 1986-02-03 Kyowa Hakko Kogyo Co Ltd 新規ヒトインタ−フエロン−rポリペプチド誘導体
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3730331A1 (de) * 1987-09-10 1989-03-30 Basf Ag Neue polypeptide, verfahren zur herstellung, die vektoren dafuer und arzneimittel daraus

Also Published As

Publication number Publication date
CA2096532A1 (en) 1992-05-20
DE4036856C1 (da) 1992-05-27
ATE163651T1 (de) 1998-03-15
JP3219274B2 (ja) 2001-10-15
ES2114555T3 (es) 1998-06-01
WO1992008737A1 (de) 1992-05-29
AU9026691A (en) 1992-06-11
EP0652903A1 (de) 1995-05-17
CA2096532C (en) 2002-12-31
JPH06502992A (ja) 1994-04-07
EP0652903B1 (de) 1998-03-04
DE59108947D1 (de) 1998-04-09

Similar Documents

Publication Publication Date Title
IT1153265B (it) Polipeptidi contenenti la sequenza degli amminoacidi dell'interferone umano immune (interferone umano gamma), relativi veicoli di espressione, loro procedimento di preparazione, composizioni farmaceutiche contenenti tali polipeptidi
HUT54213A (en) Process for the enzymatic removal of n-terminal sequence of proteins
IL85020A0 (en) Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it
ES8802161A1 (es) Procedimiento para la obtencion de peptidos
EP0722461A4 (en) EXPRESSION OF FUSION POLYPEPTIDES TRANSPORTED OUT OF CYTOPLASM WITHOUT HEAD SEQUENCE
ATE402957T1 (de) Analoge des menschlichen interferon-alpha mit niedriger toxizität
NL300013I1 (nl) Nieuwe protein met TNF-remmende werking en hun ber
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
HUT68021A (en) Improved activating process of recombinant proteins
ATE163651T1 (de) Neues menschliches, rekombinantes interferon gamma
Browning et al. Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
AU669483B2 (en) Nucleotide sequences and resistance proteins cycloheximide
ES2009588A6 (es) Un metodo para la preparacion de un polipeptido.
HUT50195A (en) New peptites hindering the activity of immune system and medical compositions containing them and process for production of these peptides and compositions
EP0330700A4 (en) Human prourokinase-like polypeptide.
ATE53606T1 (de) Mit einem herpes-simplex-virus-gen inseriertes rekombinantes plasmid.
EP0238275A3 (en) Recombinant product
ATE143974T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ES8700691A1 (es) Un metodo para sintetizar por adn recombinante un inhibidor de serin-proteasa con una unica cadena polipeptidica